For Science… From Science

Srivastava Leads Research at New England Peptide

Mass High Tech


February 16, 2009


By Ernie King - News Staff Writer

New England Peptide LLC has appointed former NEP board member Ved Srivastava as vice president for research production, where he will oversee the company production pipeline, officials reported.

Srivastava joins NEP from his former role as associate director of discovery research at Amylin Pharmaceuticals Inc. In that role, he led the discovery, synthesis and development of peptide hormones used for obesity, diabetes and neuropsychiatric treaments. His chemistry management skills also led Srivastava to direct research for Psylin Neurosciences Inc., the joint venture of Amylin and PsychoGenesis Inc.

Srivastava graduated from India’s University of Lucknow with a doctoral degree in organic chemistry. Since then, he’s held post-doctoral roles at the University of Georgia and the University of Colorado medical school.

Founded in 1998, Gardner-based NEP makes peptides used globally in drug and vaccine antibodies.


"You should receive a contact shortly from a colleague of mine. He is interested in making some phospho-specific antibodies, and given the great results we've had with you guys in the past, it was an easy recommendation to make. Cheers."
Rob S. PhD – Biogen Idec